Patent №
US 6,576,434
Granted
2003-06-10
Filed 2001
Owner
GENAERA CORPORATION
+1 more
Lab
—
AI components
1
ml
Assignment
Recorded
Dataset
AIPD
2023_r1 edition
Application
09623624
A new gene in the calcium-activated chloride channel family has been discovered that is induced by L-9, thereby providing a therapeutic target in IL-9 mediated development of atopic allergy, asthma-related disorders and cystic fibrosis. A method for the identification and use of small molecule inhibitors of this gene and its products to treat these disorders has also been discovered.
AI classification
Ownership
GENAERA CORPORATION
namechg · 120610506
MAGAININ PHARMACEUTICALS, INC.
assignment · 120800843
Assignors
HOLROYD, KENNETH J., LEVITT, ROY C., MALOY, W. LEE, LOUAHED, JAMILA, MCLANE, MIKE, NICOLAIDES, NICHOLAS C., ZHOU, YUHONG, DONG, CHARLES QU
On an employer assignment, the assignors are typically the inventors.